Fig. 4.
Fig. 4. Actuarial risk of relapse after allogeneic BMT for patients with good- (n = 25), intermediate- (n = 15), and poor- (n = 17) risk cytogenetics.

Actuarial risk of relapse after allogeneic BMT for patients with good- (n = 25), intermediate- (n = 15), and poor- (n = 17) risk cytogenetics.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal